Therapeutic Goods Administration (TGA)

Supporting Navigation of the Regulatory Landscape for Software-based Digital Health Products

The joint TGA-ANDHealth initiative will support Australian SMEs to navigate the regulatory guidance and compliance requirements for Software as a Medical Device (SaMD).

It will also provide a conduit for the digital health industry to communicate directly with the TGA, providing feedback that will strengthen future regulatory development and guidance documentation.

Click here for more information.
Opportunities for support and engagement  
Digital Health Webinars
Speakers from the TGA and live Q&A. 1st Tuesday of the month, 10 am – 11 am EST. Starts 7 Sept – Dec 2021 & Feb 2022. Book NOW for Sept, Oct webinars.
Support Navigating SaMD
One-on-one Office Hours session with ANDHealth, to support companies navigate SaMD. Bookings open September.
Feedback Portal
To gather your feedback, queries and suggestions to drive improvement and clarity to the TGA guidance provided. Portal launches September.
“Having a strong regulatory environment for digital heath products not only provides access to safe, evidence-based digital health products to improve patient outcomes, but also improves the commercial potential of new innovations.”

- Bronwyn Le Grice, CEO and Managing Director, ANDHealth

Join our
mailing list

Stay up to date on news, programs and events
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.